Eucalyptus oil/menthol/methyl salicylate/phenol

4-O-Methyl honokiol is a natural neolignan isolated from Magnolia officinalis , acts as a PPARγ agonist, and inhibtis NF-κB activity, used for cancer and inflammation research.In Vitro4-O-Methyl honokiol is a natural neolignan isolated from Magnolia

4-O-Methyl honokiol is a natural neolignan isolated from Magnolia officinalis , acts as a PPARγ agonist, and inhibtis NF-κB activity, used for cancer and inflammation research.In Vitro4-O-Methyl honokiol is a natural neolignan isolated from Magnolia

4-O-Methyl honokiol is a natural neolignan isolated from Magnolia officinalis , acts as a PPARγ agonist, and inhibtis NF-κB activity, used for cancer and inflammation research.In Vitro4-O-Methyl honokiol is a natural neolignan isolated from Magnolia

4-O-Methyl honokiol is a natural neolignan isolated from Magnolia officinalis , acts as a PPARγ agonist, and inhibtis NF-κB activity, used for cancer and inflammation research.In Vitro4-O-Methyl honokiol is a natural neolignan isolated from Magnolia

4-O-Methyl honokiol is a natural neolignan isolated from Magnolia officinalis , acts as a PPARγ agonist, and inhibtis NF-κB activity, used for cancer and inflammation research.In Vitro4-O-Methyl honokiol is a natural neolignan isolated from Magnolia

4-O-Methyl honokiol is a natural neolignan isolated from Magnolia officinalis , acts as a PPARγ agonist, and inhibtis NF-κB activity, used for cancer and inflammation research.In Vitro4-O-Methyl honokiol is a natural neolignan isolated from Magnolia

4-SEC-BUTYL-2-NITROPHENOL

A dihydroxy PUFA and a hydrolysis product of LTA4.

A dihydroxy PUFA and a hydrolysis product of LTA4.

A dihydroxy PUFA and a hydrolysis product of LTA4.

5(S)-HpEPE is a monohydroperoxy PUFA produced by the action of 5-LO on EPA. It is metabolized to LTA5, a key intermediate in the formation of the 5-series leukotrienes. Alternatively, 5(S)-HpEPE is reduced to 5(S)-HEPE by peroxidases.

5(S)-HpEPE is a monohydroperoxy PUFA produced by the action of 5-LO on EPA. It is metabolized to LTA5, a key intermediate in the formation of the 5-series leukotrienes. Alternatively, 5(S)-HpEPE is reduced to 5(S)-HEPE by peroxidases.